FASLG and autoimmune polyendocrinopathy: This subgroup of patients is mainly characterized by a persistent aPL positivity, with or without APS, and additional non-aPL-related clinical and laboratory manifestations such as cytopenia and anti-nuclear antibodies (ANA) positivity.